Evaluation Of The Efficacy And Safety Of Eplontersenin Patients With Transthyretin-mediated Amyloid Cardiomyopathy: The Cardio-ttransform Study
HFSA ePoster Library. Maurer M. 09/10/21; 343860; CTR-005
Dr. Mathew Maurer
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}